Humanin: Effects, Dosage and How This Mitochondrial Peptide Protects the Brain and Cells From Aging

Humanin is a mitochondria-derived peptide that protects neurons, reduces Alzheimer's risk markers, improves insulin sensitivity and extends lifespan in animal models. Effects, dosage and what the research actually shows.

Discovered in an unexpected place — a fragment of the brain of an Alzheimer's patient — Humanin is a mitochondria-derived peptide whose biology has turned out to be far more consequential than its origins suggested. What began as an observation about a short peptide that could protect neurons from Alzheimer's-related cell death has expanded into a research program that now spans neuroprotection, insulin signaling, cardiovascular protection, inflammation, and the fundamental biology of aging.

Like MOTS-c — its molecular sibling encoded in the same mitochondrial genome — Humanin is produced naturally by mitochondria, circulates in the bloodstream, and declines with age. Unlike MOTS-c, whose primary domain is metabolic and exercise-related, Humanin's most documented and compelling effects are neurological: it protects neurons from diverse causes of cell death with a consistency and potency that has kept it at the center of neurodegeneration research for over two decades.

This post examines the science behind Humanin: its discovery, mechanism, what the published research across multiple disease models actually shows, and what is known about its use as a research peptide.

⚠️ Important Disclaimer: Humanin is an investigational research peptide. It is not approved by the FDA or any regulatory agency for human therapeutic use. This article is for educational purposes only and does not constitute medical advice.

What Is Humanin?

Humanin is a 21-amino-acid peptide encoded by a short open reading frame within the 16S ribosomal RNA gene of the human mitochondrial genome — the same genomic region that encodes MOTS-c, its better-known metabolic sibling. It was first identified in 2001 by Dr. Nishimoto and colleagues at Osaka University, who were screening for factors that could protect neurons from the cell death induced by genes associated with familial Alzheimer's disease.

The discovery method is telling: Humanin was found by searching for sequences capable of rescuing neurons from Alzheimer's-associated toxicity. It was not found by looking for mitochondria-derived peptides — the discovery of its mitochondrial origin came later, and its classification as a mitochondria-derived peptide (MDP) was part of the broader conceptual framework that subsequently recognized mitochondria as a source of bioactive signaling peptides.

Humanin circulates naturally in human blood. Its plasma levels decline with age — with one study documenting that Humanin levels in 70-year-olds are approximately half those of 20-year-olds. This age-dependent decline correlates with increased susceptibility to neurodegeneration, metabolic disease, and the cellular stress sensitivity that characterizes aging.

A synthetic analog called HNG (Humanin-G) — in which the serine at position 14 is replaced by glycine — has been developed and is approximately 1,000 times more potent than native Humanin in most biological assays. Most research published after approximately 2005 uses HNG rather than the original Humanin sequence, and most research peptide market products labeled as "Humanin" are HNG or similarly potentiated analogs.

How Does Humanin Work?

Humanin's mechanism involves multiple receptor systems and signaling pathways, which is part of why its effects span such a wide range of biological contexts.

1. FPRL1/FPR2 Receptor Activation

Humanin binds to and activates FPRL1 (Formyl Peptide Receptor Like-1), also known as FPR2 — a G protein-coupled receptor expressed in neurons, immune cells, and other tissues. FPRL1 activation by Humanin triggers intracellular survival signaling cascades including PI3K/Akt and MAPK/ERK pathways — the same pathways that promote cell survival in response to growth factors. This receptor-mediated mechanism is the primary driver of Humanin's neuroprotective and cytoprotective effects.

2. CNTFR Complex Signaling

Humanin also signals through a receptor complex involving the ciliary neurotrophic factor receptor (CNTFR) — a cytokine receptor expressed in neurons and other cell types. This signaling pathway activates STAT3 and other transcription factors that regulate gene expression programs related to cell survival, inflammation resolution, and metabolic adaptation.

3. Bax Inhibition

One of the most directly relevant mechanisms for Alzheimer's neuroprotection: Humanin directly inhibits Bax — a pro-apoptotic protein that is upregulated by several Alzheimer's-associated factors including amyloid-beta (Aβ) oligomers, presenilin mutations, and oxidative stress. By blocking Bax-mediated apoptosis, Humanin prevents the neuron death that these toxic signals would otherwise trigger.

4. Anti-Inflammatory Signaling

Humanin reduces the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 in activated immune cells and inflamed tissue — through mechanisms that include FPRL1-mediated resolution signaling and STAT3-dependent anti-inflammatory gene programs. This anti-inflammatory activity is relevant to both neurological and systemic applications.

5. AMPK-Independent Metabolic Effects

Unlike MOTS-c, which primarily works through AMPK, Humanin's metabolic effects — including improvements in insulin sensitivity — appear to operate through partially distinct pathways. Humanin has been shown to directly improve insulin receptor substrate (IRS) signaling in peripheral tissues, reducing the molecular defects in insulin signaling that characterize type 2 diabetes.

What the Research Shows

Alzheimer's Disease and Neurodegeneration

This is Humanin's most extensively studied application and the context of its discovery. The research base spans over two decades and multiple research groups:

Humanin rescues neurons from cell death induced by multiple Alzheimer's-associated insults including amyloid-beta (Aβ42), presenilin mutations (PS1 and PS2 FAD mutants), and oxidative stress — across cell culture and animal models
In transgenic Alzheimer's mouse models, Humanin and HNG administration reduces amyloid plaque burden, improves memory performance, and reduces neuroinflammation
Human epidemiological data shows that lower circulating Humanin levels are associated with increased risk of Alzheimer's disease and cognitive decline in aging populations
Carriers of Alzheimer's risk genetic variants show reduced Humanin levels compared to non-carriers — suggesting Humanin decline may be mechanistically connected to genetic Alzheimer's risk

(View Humanin Alzheimer's research on PubMed)

Cardiovascular Protection

Humanin has documented cardioprotective effects that parallel but are mechanistically distinct from those of MOTS-c:

In animal models of myocardial ischemia-reperfusion injury, Humanin reduces infarct size and improves cardiac function — through both anti-apoptotic and anti-inflammatory mechanisms
Humanin protects vascular endothelial cells from oxidative stress and inflammatory damage — relevant to atherosclerosis and vascular aging
Lower circulating Humanin levels in humans correlate with increased carotid artery intima-media thickness — a validated marker of subclinical atherosclerosis and cardiovascular risk

Insulin Sensitivity and Metabolic Effects

Humanin improves insulin sensitivity in animal models of type 2 diabetes and diet-induced obesity — through both peripheral and hepatic mechanisms
In obese animal models, Humanin administration reduces fat mass and improves glucose tolerance, though the effects are generally less dramatic than those documented for MOTS-c
Human studies show an inverse correlation between circulating Humanin levels and markers of insulin resistance and metabolic syndrome

Longevity and Aging

The longevity biology of Humanin is among the most compelling aspects of its research profile:

In C. elegans (the nematode model organism central to longevity research), Humanin administration extends lifespan — through mechanisms involving the IGF-1 signaling pathway, one of the most conserved longevity-regulating pathways across species
In mice, long-term Humanin treatment is associated with improved survival, reduced age-related metabolic decline, and preserved cognitive function in older animals
Higher circulating Humanin levels are found in centenarians and their offspring compared to age-matched controls — providing human genetic and demographic evidence for a longevity association
The age-related decline in Humanin levels tracks closely with the hallmarks of biological aging, suggesting that Humanin deficiency may be a contributor to — not merely a marker of — the aging process

(View longevity research on PubMed)

Male Fertility

An unexpected and well-documented application: Humanin is highly expressed in Sertoli cells in the testes and has been found to protect sperm from DNA damage and apoptosis. Research has shown that Humanin levels in seminal plasma correlate with sperm motility and DNA integrity — and that exogenous Humanin protects sperm from chemotherapy-induced damage in animal models. This represents a potential clinical application that has attracted specific research interest. (View related fertility studies on PubMed)

Eye and Retinal Protection

Humanin has documented protective effects on retinal neurons and photoreceptors — relevant to conditions including age-related macular degeneration (AMD) and diabetic retinopathy. Both conditions involve progressive photoreceptor death, and Humanin's anti-apoptotic mechanisms directly address this pathology in preclinical models. (View related retinal studies on PubMed)

Effects: What Is Documented and Reported

1. Neuroprotection and Cognitive Support

The most extensively researched and mechanistically strongest application. Humanin protects neurons from Alzheimer's-associated toxins, reduces neuroinflammation, and preserves cognitive function in aged animal models. For individuals with family history of Alzheimer's, existing mild cognitive impairment, or age-related cognitive decline, the neuroprotective rationale is the primary driver of research interest in Humanin.

2. Cellular Survival Under Stress

Humanin's Bax inhibition and FPRL1-mediated survival signaling make it broadly cytoprotective — it protects cells from diverse causes of death including oxidative stress, ischemia, inflammatory cytokines, and chemotherapy-related toxicity. This broad cytoprotective activity is what gives it potential relevance across so many tissue types and disease contexts.

3. Cardiovascular Risk Reduction

The combination of cardiac muscle protection, vascular endothelial preservation, and anti-inflammatory activity makes Humanin relevant to cardiovascular aging — particularly for individuals whose circulating Humanin levels are in the lower range associated with higher atherosclerosis risk.

4. Insulin Sensitivity Improvement

Documented in preclinical models and associated inversely with insulin resistance markers in human observational data. The magnitude of Humanin's metabolic effects appears somewhat less pronounced than MOTS-c's in direct animal comparisons, but the two peptides work through complementary mechanisms that make them rational co-administration candidates.

5. Anti-Aging Effects

Lifespan extension in model organisms, longevity association in centenarians, and restoration of youthful cellular function in aged animals collectively make Humanin one of the most credible anti-aging peptides available in research contexts. Its mechanism — protecting cells from the apoptotic and inflammatory damage that accumulates during aging — targets a fundamental process of biological aging rather than a peripheral biomarker.

6. Male Fertility Support

Sperm protection from DNA damage and oxidative stress is a well-documented Humanin effect with specific clinical relevance for men with fertility concerns or those undergoing chemotherapy.

Humanin vs. MOTS-c: Complementary MDPs

Feature	Humanin	MOTS-c
Mitochondrial genome location	16S rRNA gene	12S rRNA gene
Length	21 amino acids (native); HNG analog is more commonly used	16 amino acids
Primary mechanism	FPRL1 activation, Bax inhibition, CNTFR complex signaling	AMPK activation via folate cycle/AICAR
Primary strength	Neuroprotection, cellular survival, cardiovascular protection	Metabolic regulation, insulin sensitivity, exercise adaptation
Aging association	Centenarian association; lifespan extension in C. elegans	Centenarian genetic association; metabolic restoration in aged animals
Metabolic effects	Moderate — insulin sensitivity, some fat mass reduction	Strong — insulin sensitivity, fat mass, exercise capacity
Neuroprotective effects	Strong — Alzheimer's, neurodegeneration, retinal protection	Emerging — less developed than Humanin's neurological data
Potent synthetic analog	HNG (1,000x more potent) — widely used in research	No established synthetic analog in common use
Synergy when combined	High — complementary mechanisms covering metabolic, neurological, and cellular protection dimensions of aging

Dosage and Protocol

No human clinical trial dose has been established. The following reflects animal research scaling and commonly discussed research protocols. This is not medical advice.

Parameter	Details
Typical research dose	2–4 mg per injection (native Humanin or HNG)
Route	Subcutaneous injection
Frequency	3–5 times per week
Timing	No specific fasted-state requirement
Cycle length	4–8 weeks in most research protocols; longevity-focused protocols sometimes use longer cycles with monitoring
HNG vs native Humanin	HNG is significantly more potent per unit dose — if using HNG, doses are typically lower (0.5–1 mg) to produce equivalent effects to higher native Humanin doses

Common Stacks

Stack Partner	Rationale
MOTS-c	The natural pairing — complementary mitochondria-derived peptides covering metabolic regulation (MOTS-c) and neuroprotection/cellular survival (Humanin). Most longevity researchers studying MDPs use them together.
Epithalon	Telomere protection and epigenetic anti-aging (Epithalon) combined with cellular survival and neurological protection (Humanin) — a comprehensive longevity stack targeting aging from multiple molecular angles.
Semax or Selank	Cognitive neuroprotection stack — Humanin's anti-apoptotic neuroprotection combined with Semax's BDNF-mediated cognitive enhancement or Selank's anxiolytic neuroprotection.
BPC-157	Systemic tissue repair (BPC-157) combined with cellular survival and anti-inflammatory protection (Humanin) — a broad recovery and resilience stack.

Side Effects and Safety

Humanin has a favorable safety profile in animal research, consistent with its origin as an endogenous human peptide produced naturally throughout life. Community use reports are generally positive.

Reported Side Effects (Community Use)

Injection site redness or mild irritation — the most commonly reported adverse effect
Mild fatigue in the first days of use in some users
Headache at higher doses
Occasional mild nausea
Some users report vivid dreams or changes in sleep architecture — possibly related to neurological activity

What Is Not Expected

No hormonal suppression — Humanin does not affect the GH, testosterone, estrogen, cortisol, or thyroid axes
No insulin resistance — the mechanism is insulin-sensitizing
No appetite or weight effects at typical research doses
No IGF-1 elevation

Theoretical Considerations

Cancer biology: Humanin's broad cytoprotective and anti-apoptotic activity raises the theoretical concern that it could protect cancer cells from apoptosis as effectively as it protects neurons. Some research has actually found Humanin expressed at elevated levels in certain cancer cell lines, suggesting it may contribute to cancer cell survival. This warrants caution in individuals with active malignancy or significant cancer history — as with all anti-apoptotic compounds.
IGF-1 pathway interaction: Research has documented that Humanin interacts with the IGF-1 binding protein 3 (IGFBP-3), which modulates IGF-1 bioavailability. The full implications of this interaction for IGF-1 signaling during exogenous Humanin administration are not fully characterized.

How to Reconstitute Humanin

Use bacteriostatic water for reconstitution and preservation.
Inject bacteriostatic water slowly into the vial along the inside wall.
Gently swirl until fully dissolved. Do not shake.
Store the reconstituted vial in the refrigerator (2–8°C). Do not freeze after reconstitution.
Reconstituted Humanin is typically stable for 4–6 weeks under refrigeration.

Frequently Asked Questions

Does Humanin prevent Alzheimer's disease?

Humanin protects neurons from Alzheimer's-associated toxicity in preclinical models and lower circulating levels are associated with higher Alzheimer's risk in human observational studies. Whether exogenous Humanin administration prevents or delays Alzheimer's in humans has not been tested in clinical trials. The mechanistic rationale is compelling but the translation to clinical prevention has not been established. Anyone with significant Alzheimer's risk should discuss any intervention — including research peptides — with a neurologist.

Is HNG the same as Humanin?

HNG (Humanin-G) is a synthetic analog of Humanin in which serine at position 14 is replaced by glycine. This single amino acid substitution increases potency approximately 1,000-fold in most biological assays without significantly altering the mechanism. Most research published after 2005 uses HNG, and many products sold as "Humanin" in research peptide markets are HNG or similar potentiated analogs. When reading research or sourcing product, verify whether the study or product uses native Humanin or HNG — and adjust dosing expectations accordingly.

Can Humanin and MOTS-c be injected together?

They can be administered in the same injection session — either in the same syringe or as separate injections. Their mechanisms are complementary and there are no documented interactions. Most longevity-focused researchers who use both compounds administer them together as part of an MDP protocol. Whether they can be physically mixed in the same syringe depends on the specific reconstitution conditions — when in doubt, administer separately to the same subcutaneous site.

How does Humanin relate to longevity research?

Humanin sits at the intersection of several major longevity biology themes: mitochondrial function, IGF-1 signaling, cellular apoptosis resistance, inflammation resolution, and the biology of centenarians. The finding that centenarians and their offspring have higher Humanin levels than age-matched controls — and the lifespan extension in model organisms — places it among the most biologically credible candidates in peptide-based longevity research. It is actively studied in the Cohen lab at USC and other major aging research centers.

Does Humanin help with anxiety or depression?

There is limited but suggestive research indicating that Humanin's neurological effects may extend to mood regulation — partly through its anti-inflammatory effects on brain tissue and partly through survival signaling in neurons relevant to mood circuitry. Some users report improved mood and reduced anxiety, but this is community observation rather than clinical trial data. For specific anxiety or depression treatment, evidence-based interventions remain the appropriate first-line approach.

Why is Humanin not more widely known despite 20+ years of research?

Several reasons converge: its discovery predated the broader recognition of mitochondria-derived peptides as a class, making it difficult to place in a conceptual framework; its applications span multiple specialties (neurology, endocrinology, cardiology) without fitting neatly into any one clinical pipeline; and the complexity of its receptor biology has made drug development more challenging than for simpler, single-target compounds. Its profile is now better understood, and interest in MDPs as a class has grown substantially since the MOTS-c discovery in 2015.

Where to Learn More

For research-based posts on every major longevity and neuroprotective peptide — from Humanin and MOTS-c to Epithalon, Semax, Selank, and Cerebrolysin — visit our resource library.

The Bottom Line

Humanin is a peptide that has been generating serious scientific interest for over two decades — and the depth of that interest reflects the genuine quality of the research, not marketing. Its neuroprotective effects across Alzheimer's, vascular, and oxidative stress models are among the most consistently replicated findings in mitochondria-derived peptide biology. Its association with human longevity — documented in centenarians and their offspring — provides a level of human biological evidence that most research peptides cannot match.

The gap that remains is the same as for MOTS-c: human interventional trial data confirming that exogenous Humanin administration in aging individuals reproduces the protective effects seen in animal models. That evidence does not yet exist. But the preclinical foundation for pursuing it is more solid than for most compounds at a comparable stage of development.

Used together, MOTS-c and Humanin form a mitochondria-derived peptide pairing that addresses aging from both the metabolic efficiency angle (MOTS-c) and the cellular survival and neuroprotection angle (Humanin) — a combination grounded in the biology of how mitochondria naturally communicate the body's health status to its cells.

The next post covers Cerebrolysin — the neuropeptide mixture derived from pig brain that has been used clinically in stroke and dementia treatment across Europe and Asia for decades. Stay tuned.

HOME

Thursday, March 19, 2026